论文部分内容阅读
原发性肝癌(以下简称肝癌)的死亡率在全世界所有癌症中占第三位川,是我国第二位癌症死亡原因。经过几十年的努力,肝癌临床和基础研究取得了许多进展,手术切除是肝癌获得长期生存的主要手段,在某些临床中心,肝癌根治性切除后5年生存率可达到40%以上(我所治疗的肝癌病人的
The mortality rate of primary liver cancer (hereinafter referred to as liver cancer) is the third highest in all cancers in the world, which is the second leading cause of cancer death in China. After decades of efforts, many advances have been made in the clinical and basic research of liver cancer. Surgical resection is the primary means of long-term survival of liver cancer. In some clinical centers, the 5-year survival rate after radical resection of liver cancer can reach over 40% The treatment of liver cancer patients